KORU MEDICAL SYSTEMS INC (KRMD)

KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth

KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024

KORU Medical Systems Announces Successful Appeal in EU Notified Body Review

The Penny Stock A-List: 7 High-Profile Companies on the Verge of Greatness

Although speculation can be bad for your blood pressure, these compelling penny stocks have some strong endorsements.

KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference

KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance

KORU Medical Systems Announces a Feasibility Study to Enter Ambulatory Infusion Settings with a Commercialized Biologic

KORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous Immunoglobulin

KORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024

KORU Medical Systems to Participate in Piper Sandler’s 35th Annual Healthcare Conference

KORU Medical Systems, Inc. to Host Investor Day on December 5, 2023

KORU Medical Systems, Inc. Announces Development Agreement for Next-generation Subcutaneous Immunoglobulin Infusion System

KORU Medical Systems, Inc. Appoints Ken Miller as Chief Commercial Officer

KORU Medical Systems, Inc. Announces 2023 Third Quarter Financial Results and Updates Full Year 2023 Outlook

KORU Medical Systems, Inc. Receives FDA 510(k) Clearance for FREEDOM60® Infusion System With Hizentra® 50 ML Prefilled Syringes

KORU Medical Systems to Participate in Upcoming Investor Conferences

KORU Medical Systems to Report Third Quarter Financial Results on November 8, 2023

KORU Medical Systems to Present Two Abstracts at the Immunoglobulin National Society 2023 National Conference

KORU Medical Systems, Inc. Announces Appointment of Edward Wholihan to Its Board of Directors

KORU Medical Systems to Participate in the Gilmartin Group Emerging Growth Company Showcase

Breaking The Hospital Chain: Analyst On How KORU's Self-Administered Therapies Promise 20% CAGR Through 2026

B.

KORU Medical Systems, Inc. Announces 2023 Second Quarter Financial Results and Updates Full Year 2023 Outlook

KORU Medical Systems to Participate in the Genuity 43rd Annual Growth Conference

KORU Medical Systems, Inc. Announces Preliminary Second Quarter 2023 Revenues and Provides Business, Outlook and Executive Updates

KORU Medical Systems to Report Second Quarter Financial Results on August 9, 2023

KORU Medical Systems Announces Novel Therapies Collaboration for Late-Stage Endocrinological Biologic

KORU Medical Systems, Inc. Announces 510(K) Submission for Freedom60® Infusion System With Hizentra® 50 Ml Prefilled Syringes

KORU Medical Systems appoints CFO (NASDAQ: KRMD)

Medical technology company KORU Medical Systems (KRMD) said on Tuesday that it has appointed Andrew LaFrence CFO, effective July 10.

KORU Medical Systems, Inc. Names Andrew LaFrence as Chief Financial Officer

KORU Medical Systems, Inc. Announces 2023 First Quarter Financial Results

KORU Medical Systems to Report First Quarter Financial Results on May 4, 2023

KORU Medical Systems Announces 2022 Q4 and Full Year Financial Results, Accelerating to 19% Revenue Growth in 2022